Trials / Completed
CompletedNCT03534375
Gender Differences of Neuroanatomical and Neurophysiological Correlates of Risk-proneness in Early Adolescents
Gender Differences in Risk-proneness, Gratification Delay, Self-control, Self-efficacy, Executive Functions and Their Neurophysiological and Neuroanatomical Correlates in Early Adolescents
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 8 (actual)
- Sponsor
- Texas Tech University · Academic / Other
- Sex
- All
- Age
- 10 Years – 12 Years
- Healthy volunteers
- Accepted
Summary
Risk-taking in early adolescence have has been found to be normative and even formative as it might fulfill the youth's needs to experiment different sensations, make independent decisions and learn from their consequences. Several theoretical models have suggested that male and female adolescents differ in risk-taking as a product of individual/contextual factors and neocortical functioning; however, the neurophysiological and neuropsychological correlates of those differences continue to be underexplored. Informed by Evolutionary Neuroandrogenic Theory, the investigators examine the links between gender, risk-proneness, gratification delay, self-control, self-efficacy, executive functions and neurophysiological-neuroanatomical correlates in early adolescents (age 10-12 years). Participants (N=24; 50% females) will complete behavioral measurements on study constructs and perform neuropsychological tests using fMRI scanning (e.g., Go/NoGo continuous performance, stop-signal reaction time, NIH Cognition Battery, delay discounting). Female and male groups will be compared on all outcome measures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | The study is an observational cross sectional study | An intervention will not be performed |
Timeline
- Start date
- 2018-05-14
- Primary completion
- 2019-04-30
- Completion
- 2019-08-31
- First posted
- 2018-05-23
- Last updated
- 2021-10-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03534375. Inclusion in this directory is not an endorsement.